Back to NBIX
Stanley-Laman Group, Ltd. → NBIX
Stanley-Laman Group, Ltd. NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$3.8M
Q3 2026
Peak value
$4.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.6M |
| Q4 2025 | $3.9M |
| Q1 2026 | $3.6M |
| Q2 2026 | $4.6M |
| Q3 2026 | $3.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.8M | 26.8K | — | — |
| Q2 2026 | $4.6M | 27.4K | — | — |
| Q1 2026 | $3.6M | 27.5K | — | — |
| Q4 2025 | $3.9M | 27.6K | — | — |
| Q3 2025 | $3.6M | 25.4K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M